Active surveillance preferred for low-risk prostate cancer

被引：0
|
作者：
Bagcchi, Sanjeet
机构：
来源：
LANCET ONCOLOGY | 2015年 / 16卷 / 08期
关键词：
D O I：
10.1016/S1470-2045(15)00155-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E384 / E384
页数：1
相关论文
共 50 条
  • [21] THE ERA OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IS HERE
    Sountoulides, Petros
    Obek, Can
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (02): : 49 - 51
  • [22] Active Surveillance for Low-risk Prostate Cancer: Will it Become Obsolete?
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2019, 75 (05) : 750 - 751
  • [23] Super active surveillance for low-risk prostate cancer | Opinion: No
    Ghodoussipour, Saum
    Lebastchi, Amir
    Pinto, Peter
    Berger, Andre
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 215 - 219
  • [24] THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER
    Levy, Mya E.
    Meyers, Stephanie
    Wood, David P.
    Montie, James E.
    Miller, David C.
    Wei, John T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 179 - 179
  • [25] Active surveillance beats surgery in low-risk prostate cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [26] Active Surveillance for Low-risk Prostate Cancer: Developments to Date
    Bangma, Chris H.
    Valdagni, Riccardo
    Carroll, Peter R.
    van Poppel, Hein
    Klotz, Laurence
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2015, 67 (04) : 646 - 648
  • [27] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [28] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [29] Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino, Sebastiano
    Privitera, Salvatore
    Favilla, Vincenzo
    Cantiello, Francesco
    Manno, Stefano
    Cicione, Antonio
    Damiano, Rocco
    Russo, Giorgio Ivan
    Morgia, Giuseppe
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 958 - 963
  • [30] Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer
    Srivastava, Arnav
    Kaufman, Samuel R.
    Shay, Addison
    Oerline, Mary
    Liu, Xiu
    Van Til, Monica
    Linsell, Susan
    Labardee, Corinne
    Dall, Christopher
    Faraj, Kassem S.
    Maganty, Avinash
    Borza, Tudor
    Ginsburg, Kevin
    Hollenbeck, Brent K.
    Shahinian, Vahakn B.
    JAMA NETWORK OPEN, 2025, 8 (01)
12345